Effects of Yohimbine and Naltrexone on Sexual Function
Erectile Dysfunction
About this trial
This is an observational trial for Erectile Dysfunction focused on measuring Yohimbine, Naltrexone, Sexual Function, Erectile Dysfunction, Alpha-2 Adrenoreceptor, Opiate Receptor, Male Impotence, ED, Healthy Volunteer, HV, Normal Control
Eligibility Criteria
INCLUSION CRITERIA Subjects must be medically healthy and free of mental illness, take no medication, and must report no problems with their sexual function. They are required to be sexually active, including successful penetrative sexual intercourse acts. For assessments of sexual function before and after the study subjects are required to complete a detailed daily diary recording their erectile activity for 7 days before the first study session, and for 7 days after completion of the study. EXCLUSION CRITERIA Persons having taken antidepressant or other medications likely to alter monoamine neurochemistry or cerebrovascular and cardiovascular function within 6 months prior to the study will be excluded. Individuals will also be excluded if they have: a) evidence for an axis I psychiatric disorder (DSM-IV criteria), b) medical or neurological illnesses likely to affect physiology or anatomy, c) a history of drug (including BZDs) or alcohol abuse within 1 year or a lifetime history of alcohol or drug dependence (DSM IV criteria), d) smokers, e) diagnosis of a sexual disorder, f) criminal history. Persons must exhibit no or only moderate alcohol use. Persons with current or previous regular use ( more than 4 weeks) of BZDs and excessive use of alcohol (more than 8 ounces/day) in the past or presence are ineligible to participate, as such drug use confound the results. Individuals beyond age 50 are excluded because subjects beyond age 50 have a far greater likelihood of showing subtile, albeit clinical irrelevant disturbances in erectile function.
Sites / Locations
- National Institute of Mental Health (NIMH)